Top Markets
#1 QuantixAI QuantixAI +64.59%
#2 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +32.54%
#3 MowCat MowCat +29.93%
#4 UnifAI Network UnifAI Network +29.38%
#5 MarsCoin MarsCoin +28.80%
#6 Prom Prom +28.32%
#7 GEKKO GEKKO +28.28%
#8 Kinesis Silver Kinesis Silver +24.57%
#9 Versatize Coin Versatize Coin +16.65%
#10 Pons Pons +15.79%
Coin of the day
QuantixAI QuantixAI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
JETEMA, Co., Ltd. JETEMA, Co., Ltd.

JETEMA, Co., Ltd.

216080
Kedudukan dalam Saham #20313
Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm... Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm dedicated to the innovation and development of pharmaceuticals and medical technologies. Their comprehensive portfolio encompasses a range of advanced solutions, including aesthetic treatments such as botulinum toxins, dermal fillers, and specialized anti-aging remedies, along with medical lifting threads. Additionally, they provide laser surgical instruments and hyaluronic acid masks for skincare.
Harga Saham
$3.60
Modal Pasaran
$133.80M
Perubahan (1 hari)
3.38%
Perubahan (1 tahun)
-18.00%
Negara
KR
Perdagangan JETEMA, Co., Ltd. (216080)

Kategori

Healthcare
Sejarah hasil dividen untuk JETEMA, Co., Ltd. (216080)
Hasil dividen (TTM) bagi JETEMA, Co., Ltd. (simbol saham: 216080) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk JETEMA, Co., Ltd. (216080) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH